Your Article Summary
See Latest ArticlesThe effect of pharmaceutical intervention on lipid profile in polycystic ovary syndrome
Obesity Reviews, 07/02/09
Diamanti-Kandarakis E et al. - The polycystic ovary syndrome (PCOS), a prevalent endocrinopathy of women, has been associated with a clustering of adverse metabolic features, which co-exist with reproductive dysfunction. Lipid abnormalities are very common in lean as well as obese women with PCOS and should be cautiously considered in the therapeutic management of the syndrome.
Related Articles
Genotype and haplotype determination of interleukin (IL) 1beta and IL-1RN in polycystic ovary syndrome
Fertility and Sterility, 11/12/09
Relevance Score: 82%
Different phenotypes of polycystic ovary syndrome by Rotterdam criteria are differently steroidogenic but similarly insulin resistant
Fertility and Sterility, 10/06/09
Relevance Score: 82%
Dissociation of endothelial function and arterial stiffness in nonobese women with polycystic ovary syndrome (PCOS)
Clinical Endocrinology, 11/17/09
Relevance Score: 81%
Prevalence and risk of depressive disorders in women with polycystic ovary syndrome (PCOS)
Fertility and Sterility, 11/10/09
Relevance Score: 81%
Criteria for Polycystic Ovarian Morphology in Polycystic Ovary Syndrome as a Function of Age
Journal of Clinical Endocrinology and Metabolism, 11/06/09
Relevance Score: 80%
Today in Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Treatment with alpha-lipoic acid reduces asymmetric dimethylarginine in patients with type 2 diabetes mellitus
Translational Research, The Journal of Laboratory and Clinical Medicine, 12/11/09
Changes in levels of haemoglobin A 1c during the first 6 years after diagnosis of clinical type 2 diabetes
Scandinavian Journal of Clinical and Laboratory Investigation, 12/11/09
Are short women at risk for gestational diabetes mellitus
European Journal of Endocrinology, 12/11/09